PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVAV vs. CORT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AVAV and CORT is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AVAV vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AeroVironment, Inc. (AVAV) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%AugustSeptemberOctoberNovemberDecember2025
2.75%
63.25%
AVAV
CORT

Key characteristics

Sharpe Ratio

AVAV:

0.73

CORT:

2.74

Sortino Ratio

AVAV:

1.41

CORT:

3.29

Omega Ratio

AVAV:

1.20

CORT:

1.40

Calmar Ratio

AVAV:

1.11

CORT:

3.27

Martin Ratio

AVAV:

2.36

CORT:

15.23

Ulcer Index

AVAV:

16.36%

CORT:

8.06%

Daily Std Dev

AVAV:

53.15%

CORT:

44.90%

Max Drawdown

AVAV:

-61.02%

CORT:

-94.28%

Current Drawdown

AVAV:

-28.25%

CORT:

-9.10%

Fundamentals

Market Cap

AVAV:

$4.76B

CORT:

$5.80B

EPS

AVAV:

$1.74

CORT:

$1.26

PE Ratio

AVAV:

96.98

CORT:

43.90

PEG Ratio

AVAV:

1.72

CORT:

0.61

Total Revenue (TTM)

AVAV:

$761.50M

CORT:

$493.15M

Gross Profit (TTM)

AVAV:

$293.79M

CORT:

$485.22M

EBITDA (TTM)

AVAV:

$77.21M

CORT:

$111.81M

Returns By Period

The year-to-date returns for both investments are quite close, with AVAV having a 9.65% return and CORT slightly higher at 9.76%. Over the past 10 years, AVAV has underperformed CORT with an annualized return of 20.86%, while CORT has yielded a comparatively higher 34.18% annualized return.


AVAV

YTD

9.65%

1M

8.13%

6M

2.75%

1Y

36.38%

5Y*

19.01%

10Y*

20.86%

CORT

YTD

9.76%

1M

5.51%

6M

63.25%

1Y

123.57%

5Y*

33.89%

10Y*

34.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AVAV vs. CORT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAV
The Risk-Adjusted Performance Rank of AVAV is 7373
Overall Rank
The Sharpe Ratio Rank of AVAV is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of AVAV is 6969
Sortino Ratio Rank
The Omega Ratio Rank of AVAV is 7171
Omega Ratio Rank
The Calmar Ratio Rank of AVAV is 8181
Calmar Ratio Rank
The Martin Ratio Rank of AVAV is 6969
Martin Ratio Rank

CORT
The Risk-Adjusted Performance Rank of CORT is 9595
Overall Rank
The Sharpe Ratio Rank of CORT is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of CORT is 9494
Sortino Ratio Rank
The Omega Ratio Rank of CORT is 9191
Omega Ratio Rank
The Calmar Ratio Rank of CORT is 9595
Calmar Ratio Rank
The Martin Ratio Rank of CORT is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AVAV vs. CORT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AeroVironment, Inc. (AVAV) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AVAV, currently valued at 0.73, compared to the broader market-2.000.002.004.000.732.74
The chart of Sortino ratio for AVAV, currently valued at 1.41, compared to the broader market-4.00-2.000.002.004.001.413.29
The chart of Omega ratio for AVAV, currently valued at 1.20, compared to the broader market0.501.001.502.001.201.40
The chart of Calmar ratio for AVAV, currently valued at 1.11, compared to the broader market0.002.004.006.001.113.27
The chart of Martin ratio for AVAV, currently valued at 2.36, compared to the broader market-10.000.0010.0020.002.3615.23
AVAV
CORT

The current AVAV Sharpe Ratio is 0.73, which is lower than the CORT Sharpe Ratio of 2.74. The chart below compares the historical Sharpe Ratios of AVAV and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
0.73
2.74
AVAV
CORT

Dividends

AVAV vs. CORT - Dividend Comparison

Neither AVAV nor CORT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AVAV vs. CORT - Drawdown Comparison

The maximum AVAV drawdown since its inception was -61.02%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AVAV and CORT. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-28.25%
-9.10%
AVAV
CORT

Volatility

AVAV vs. CORT - Volatility Comparison

The current volatility for AeroVironment, Inc. (AVAV) is 9.75%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 10.76%. This indicates that AVAV experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
9.75%
10.76%
AVAV
CORT

Financials

AVAV vs. CORT - Financials Comparison

This section allows you to compare key financial metrics between AeroVironment, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab